Cite
Lin XB, Lui KY, Guo PH, et al. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction. Pharmacotherapy. 2021;42(1):23-33doi: 10.1002/phar.2634.
Lin, X. B., Lui, K. Y., Guo, P. H., Liu, X. M., Liang, T., Hu, X. G., Tong, L., Wu, J. J., Xia, Y. Z., Chen, P., Zhong, G. P., Chen, X., & Cai, C. J. (2022). Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction. Pharmacotherapy, 42(1), 23-33. https://doi.org/10.1002/phar.2634
Lin, Xiao-Bin, et al. "Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction." Pharmacotherapy vol. 42,1 (2022): 23-33. doi: https://doi.org/10.1002/phar.2634
Lin XB, Lui KY, Guo PH, Liu XM, Liang T, Hu XG, Tong L, Wu JJ, Xia YZ, Chen P, Zhong GP, Chen X, Cai CJ. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction. Pharmacotherapy. 2022 Jan;42(1):23-33. doi: 10.1002/phar.2634. Epub 2021 Oct 25. PMID: 34655497.
Copy
Download .nbib
